Results 71 to 80 of about 1,720 (164)
Radiotherapy for isolated granulocytic sarcoma: Case report and review of literature
•Isolated chloroma should be considered as a systemic disease.•Consolidation radiotherapy has been related with prolonged failure free survival.•Excellent local control of chloroma is achieved with low-dose ...
Fernández Lizarbe, Eva +9 more
core +1 more source
A: Tissue section of an EOL-1 chloroma of selectin wt scid mouse. Immunohistochemical staining for human HLA-DR in red. B: Tissue section of a K562 chloroma of a wt scid mouse. Immunohistochemical staining for human mitochondria in red.
Anna Schmidt (279368) +5 more
core +1 more source
Acute Philadelphia Chromosome Positive Biphenotypic Leukemia Presenting with Bilateral Orbital Chloroma: A Rare Case Report [PDF]
Introduction: Chloromas are characteristically formed by the extramedullary soft tissue infiltration by the immature myeloid malignant cells. Such extramedullary masses are most commonly seen in acute myeloid leukemia usually in the M2, M4, M5 subtypes ...
LK, Rajeev +6 more
core
Myeloid sarcoma (MS), granulocytic sarcoma or chloroma, is defined as a localized extramedullary mass of blasts of granulocytic lineage with or without maturation, occurring outside the bone marrow.
Joana Ruivo Rodrigues +3 more
doaj +1 more source
Unilateral Proptosis As An Initial Sign Of Acute Myeloid Leukemia In A Child: A Case Report
Ashwaq Mohammed J Almalki,1 Faisal Ali Alotaibi,1 Hatim Fawzi Jabr,1 Abdul Rehman Mastan2 1Ophthalmology Department, King Abdulaziz Specialist Hospital, Taif, Kingdom of Saudi Arabia; 2ENT Department, King Abdulaziz Specialist Hospital, Taif, Kingdom of ...
Almalki AMJ +3 more
doaj
Primary Vaginal Chloroma: A Rare Case Report
Chloroma (granulocytic sarcoma or myeloid sarcoma) is a rare malignant extra-medullary neoplasm of myeloid precursor cells. It is usually associated with myeloproliferative disorders but very rarely may precede the onset of leukaemia.
Irappa Madabhavi +4 more
doaj
MR images of one mouse each of the therapy (A, imatinib) and placebo group (B). Coronar (left panels) and sagittal (left panels) T2 images of EOL-1 bearing scid mice on days 27 (d0 of treatment), 30 (d3 of treatment) and 34 (d7 of treatment).
Nuno Ramos Leal (333204) +7 more
core +1 more source
The presence of human EOL-1 cells was ascertained by labeling for human HLA-DR (seen in red) in tissue-sections. (A) chloroma, placebo group; (B) former chloroma, therapy group with no viable EOL-1 cells detectable; (C) spleen, placebo; (D) spleen ...
Nuno Ramos Leal (333204) +7 more
core +1 more source

